Last Posted: Jun-07-2019 1PM
Last Posted: Jun 03, 2019
- Pancreatic cancer therapy sheds light on the disease's ties to BRCA mutation
J Howard, CNN, June 2, 2019 - BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestry.
Friebel Tara M et al. Human mutation 2019 May - Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
Kemp Zoe et al. JAMA network open 2019 May 2(5) e194428 - The Role of BRCA Testing in Hereditary Pancreatic and Prostate Cancer Families.
Pilarski Robert et al. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2019 Jan 3979-86 - Cancer genetic health communication in families tested for hereditary breast/ovarian cancer risk: a qualitative investigation of impact on children's genetic health literacy and psychosocial adjustment.
Tercyak Kenneth P et al. Translational behavioral medicine 2019 May 9(3) 493-503 - Uptake of testing for germline BRCA mutations in patients with non-mucinous epithelial ovarian cancers in Western Australia: a comparison of different genetic counseling methods.
Stearnes Grace et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2019 May - Accuracy in risk understanding among BRCA1/2-mutation carriers.
Speiser Dorothee et al. Patient education and counseling 2019 May - Clinical significance of variants of unknown significances in BRCA genes.
Choi Min Chul et al. Journal of gynecologic oncology 2019 May - The influence of BRCA variants of unknown significance on cancer risk management decision-making.
Chern Jing Yi et al. Journal of gynecologic oncology 2019 Feb - Understanding BRCA Mutation Carriers' Preferences for Communication of Genetic Modifiers of Breast Cancer Risk.
Hovick Shelly R et al. Journal of health communication 2019 May 1-8
No hay comentarios:
Publicar un comentario